Massimo Cristofanilli
Breast Center at Weill Cornell Medicine
Office
(646) 962-2330
1283 York Avenue 4th Floor New York, NY 10065
About
Massimo Cristofanilli
Massimo Cristofanilli, MD, is an accomplished board-certified medical oncologist with more than two decades of experience as physician, investigator, researcher and leader. He has demonstrated original and innovative vision in the field of molecular diagnostics, liquid biopsy, translational research and drug development. Additionally, Dr. Cristofanilli has an extensive background in clinical trial design and is a key thought leader in the field of metastatic and locally advanced breast cancer.At Weill Cornell Medicine and NewYork-Presbyterian, Dr. Cristofanilli serves as the Director of Breast Medical Oncology, the Associate Director of Precision Oncology at the Meyer Cancer Center (MCC), and the co-leader of the MCC Breast Cancer Disease Management Team, as well as the Scientific Director of the Englander Institute of Precision Medicine (EIPM).Dr. Cristofanilli received his medical degree from the University “La Sapienza” in Rome with Honors where he subsequently completed his fellowship in medical oncology. He completed an Internal Medicine residency at Cabrini Medical Center in New York and a medical oncology fellowship at The University of Texas MD Anderson Cancer Center, where he also served as Faculty in the Department of Breast Medical Oncology for more than a decade.Dr. Cristofanilli has held several leadership positions over the years, including Chair of Medical Oncology and Associate Director of Clinical Research at the Fox Chase Cancer Center and Associate Director of Translational Research at Thomas Jefferson University. From 2015-2021, Dr. Cristofanilli was Professor of Medicine at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago where he also served as the Director of the Breast Disease Team, Director of the Robert Lurie Cancer Center OncoSET Precision Medicine Program, and Associate Director of Clinical Research.In addition to his clinical expertise, Dr. Cristofanilli’s research focuses on biomarkers of endocrine resistance in breast cancer, liquid biopsies and novel drug development. His research in the areas of novel drug development, circulating tumor cells (CTCs) and ctDNA have led to improved treatments for breast cancer. Dr. Cristofanilli is an internationally recognized expert in the research and treatment of Inflammatory Breast Cancer (IBC), the most aggressive and deadly form of breast cancer. He is the founder and President of the IBC International Consortium (IBC-IC). Additionally, Dr. Cristofanilli is globally recognized for his contributions on the detection of micrometastatic disease in breast cancer and a key opinion leader in drug development in hormone-receptor positive metastatic breast cancer. He has co-authored more than 400 peer-reviewed manuscripts.
Primary Specialty
Oncologist
Practice
Breast Center at Weill Cornell Medicine
Gender
Male
Not Accepting New Patients
Insurances Accepted
Aetna - NYP, Empire Blue Cross/Blue Shield, VNSNY CHOICE, AETNA, United Healthcare, Health Insurance Plan of NY (HIP), Oxford Health Plans, GHI, Empire Blue Cross/Blue Shield Healthplus, CIGNA
Degrees
Medical Doctor
Office Name
Breast Center at Weill Cornell Medicine
Languages
English, Italian
Services
Breast Center at Weill Cornell Medicine provides oncology services in New York, NY. Oncology includes the diagnosis and treatment of breast cancer, skin cancer, prostate cancer, and many other forms of cancer.
Contact Massimo Cristofanilli at (646) 962-2330 for specific information about cancer treatment in New York, NY. Additional Services Hematologist
Contact Massimo Cristofanilli at (646) 962-2330 for specific information about cancer treatment in New York, NY. Additional Services Hematologist
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!
©2024 Wellness®.com is a registered trademark of Wellness.com, Inc. 